UNSPSC 85801055: Change cast on left upper leg

This classification denotes the group of activities that yields a placement intervention or procedure to change cast on left upper leg. This placement intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 2W0PX2Z

UNSPSC 85801055 Change cast on left upper leg is a Commodity code that sees virtually no relevant recent state and local procurement activity. The code nominally describes orthopedic casting services—a clinical procedure—yet the recent opportunities block contains no solicitations for casting, cast changes, orthopedic care, or related clinical interventions. Instead, the twenty-five most recent state and local opportunities tagged to or near this code span clinical laboratory testing (lead analysis, drug screening, occupational health surveillance), pharmacy benefit management, histology services, wastewater testing, inmate medical care, onsite occupational medicine, and firefighter physicals. These are substantively unrelated to the orthopedic scope the code name suggests, indicating either tagging inconsistency in the source data or a fundamental mismatch between the code's nominal definition and how state and local procurement offices use it in practice.

The absence of orthopedic casting or cast-change solicitations across the recent opportunities block—which spans Illinois, Texas, Kentucky, Michigan, Colorado, Georgia, Florida, Nevada, Oregon, and Washington, D.C.—signals that this code either carries minimal procurement volume in the state and local market or is rarely applied to actual casting services. Vendors evaluating this code should verify whether their target state or local customers use 85801055 consistently and check directly with procurement offices in priority jurisdictions rather than rely on recent opportunity patterns to inform pursuit strategy. The code appears inactive or severely underutilized at the state and local level as of mid-2026.